首页 | 本学科首页   官方微博 | 高级检索  
     

重症肌无力胸腺摘除前后血清抗乙酰胆碱受体抗体、抗突触前膜抗体及可溶性白细胞介素_2受体的变化
引用本文:张清勇,魏云,王铁栓,杜英,张斌,王宪忠. 重症肌无力胸腺摘除前后血清抗乙酰胆碱受体抗体、抗突触前膜抗体及可溶性白细胞介素_2受体的变化[J]. 中华实验外科杂志, 1999, 0(3)
作者姓名:张清勇  魏云  王铁栓  杜英  张斌  王宪忠
作者单位:河南医科大学第二附属医院胸外科!郑州,450003,河南医科大学第二附属医院胸外科!郑州,450003,河南医科大学第二附属医院胸外科!郑州,450003,河南医科大学微生物学与免疫学教研室,河南医科大学第二附属医院胸外科!郑州,450003,河南省永城县人民医院
基金项目:河南省自然科学基金!964021500
摘    要:目的探讨胸腺摘除对重症肌无力患者血清抗乙酸胆感受体抗体、抗灾触前膜抗体(AchRab)、(PrM))和可溶性白细胞介素2受体(sIL-2R)水平的影响。方法采取39例重症肌无力(myastheniagravis,MG)患者在胸腺摘除前后和40例健康献血员血清,用ELISA法检出AchRab、PrM及sIL-2R的水平。结果64.2%的重症肌无力患者血清AchRab显著增高,27.5%的重症肌无力患者PsmRab显著增高,AchRab和PrM同时增高者占15%。重症肌无力患者血清sIL-2R显著高于正常者占79.6%。三项指标在胸腺摘除后有显著下降的比例分别为48%、45%、32%。结论胸腺摘除对外周血中的AchRab、PrM、sIL-2R有明显下调作用。

关 键 词:重症肌无力  胸腺摘除  AchRab  PrM  可溶性白细胞介_2素受体

Serum AchRab, PrM and sIL-2R in patients with myasthenia Gravis before and after thymectomy
ZHAN Qingpong, WEI Yun, WANG Tieshuan. Serum AchRab, PrM and sIL-2R in patients with myasthenia Gravis before and after thymectomy[J]. Chinese Journal of Experimental Surgery, 1999, 0(3)
Authors:ZHAN Qingpong   WEI Yun   WANG Tieshuan
Abstract:Objective To investigate the changes in serum AchRab, PrM, sIL-2R in patients withmyasthenia Gravis (MG) before and after thymectomy. Method Serum AchRab. PrM, and sIb-2R in MGpatients were determined with ELISA. Results The positive rate of AchRab and PrM in MG patients was64. 2 % and 27. 5 % respectively. The peitive rate of both AchRab and PrM in MG patients was 15 %. SerumsIL-2R level of 79. 6% MG patients was obviously increased as compared with that of normal subjects. Afterthymectomy, the titers of AchRab, PrM and sIL-2R were markedly decreased with the ratio beng 48%,45% and 32% respectively. Conclusion Thyrnectomy could induce the down-regulation of serum AchRab,PrM and sIL-2R.
Keywords:Myasthenia Gravis  Thyrnectomy   AchRab  PrM   sIL-2R
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号